Edition:
United Kingdom

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

424.40SEK
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
424.40kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,329
52-wk High
516.00kr
52-wk Low
290.00kr

Chart for

About

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi... (more)
No analyst recommendations are available for .

Overall

Beta: 0.37
Market Cap(Mil.): kr3,982.29
Shares Outstanding(Mil.): 11.64
Dividend: 1.00
Yield (%): 0.29

Financials

  PROB.ST Industry Sector
P/E (TTM): 28.10 22.52 40.76
EPS (TTM): 12.17 -- --
ROI: 22.06 12.26 62.30
ROE: 22.17 15.63 73.91

BRIEF-Probi Q1 Net Sales Fall To SEK 119.2 Million

* Q1 OPERATING PROFIT SEK 4.4 MILLION VERSUS SEK 48.7 MILLION YEAR AGO

02 May 2018

BRIEF-Probi: Positive Results Of Probi's Probiotic Supplement

* PROBI ENTERS THE BONE HEALTH AREA - A NEW AREA FOR PROBIOTICS

11 Apr 2018

BRIEF-Probi Signs Long-Term Agreement With Cilag

* HAS SIGNED A LONG-TERM AGREEMENT WITH CILAG, A MEMBER OF THE JOHNSON & JOHNSON FAMILY OF COMPANIES FOR THE DEVELOPMENT OF A PROBIOTIC PRODUCT

22 Mar 2018

BRIEF-Probi Appoints Ole Søgaard Andersen As Interim CEO

* ‍ANNOUNCED APPOINTMENT OF OLE SØGAARD ANDERSEN AS INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY.​

14 Mar 2018

Earnings vs. Estimates